These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34367485)

  • 21. Designing precision medicine panels for drug refractory cancers targeting cancer stemness traits.
    Warrier S; Patil M; Bhansali S; Varier L; Sethi G
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188475. PubMed ID: 33188876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinical Impact of Cancer Stem Cells.
    Lathia J; Liu H; Matei D
    Oncologist; 2020 Feb; 25(2):123-131. PubMed ID: 32043793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance.
    Lee G; Hall RR; Ahmed AU
    J Stem Cell Res Ther; 2016 Oct; 6(10):. PubMed ID: 27891292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of Cancer Stem Cells and Stemness for Community Oncologists.
    Lathia JD; Liu H
    Target Oncol; 2017 Aug; 12(4):387-399. PubMed ID: 28664387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stem cells in small cell lung cancer.
    Codony-Servat J; Verlicchi A; Rosell R
    Transl Lung Cancer Res; 2016 Feb; 5(1):16-25. PubMed ID: 26958490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heat shock proteins in cancer stem cell maintenance: A potential therapeutic target?
    Lettini G; Lepore S; Crispo F; Sisinni L; Esposito F; Landriscina M
    Histol Histopathol; 2020 Jan; 35(1):25-37. PubMed ID: 31322279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Formation, Stemness and Therapeutic Resistance of Cancer Stem Cells.
    Jing N; Gao WQ; Fang YX
    Front Cell Dev Biol; 2021; 9():641498. PubMed ID: 33898430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies.
    Limonta P; Chiaramonte R; Casati L
    Cancers (Basel); 2024 Aug; 16(16):. PubMed ID: 39199632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.
    Fang X; Yan Q; Liu S; Guan XY
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro models of cancer stem cells and clinical applications.
    S Franco S; Szczesna K; Iliou MS; Al-Qahtani M; Mobasheri A; Kobolák J; Dinnyés A
    BMC Cancer; 2016 Sep; 16(Suppl 2):738. PubMed ID: 27766946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression.
    Ponomarev A; Gilazieva Z; Solovyeva V; Allegrucci C; Rizvanov A
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset.
    Agnoletto C; Corrà F; Minotti L; Baldassari F; Crudele F; Cook WJJ; Di Leva G; d'Adamo AP; Gasparini P; Volinia S
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30959764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy.
    Papadaki S; Magklara A
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential.
    Darini CY; Martin P; Azoulay S; Drici MD; Hofman P; Obba S; Dani C; Ladoux A
    Cell Death Dis; 2013 Jul; 4(7):e706. PubMed ID: 23828569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.